Matinas BioPharma Holdings (MTNB) Capital Leases (2014 - 2026)
Matinas BioPharma Holdings (MTNB) reported Capital Leases of $5000.0 for Q1 2026, down 54.55% year-over-year from $11000.0 in Q1 2025, and little changed quarter-over-quarter from $5000.0 in Q4 2025.
Matinas BioPharma Holdings (MTNB) Capital Leases (2014 - 2026) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has 12 years of Capital Leases data on file, last reported at $5000.0 in Q1 2026.
- Capital Leases for Q1 2026 came in at $5000.0, down 54.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $5000.0 (down 54.55% YoY), and the FY2025 annual result was $5000.0, down 58.33% from the prior year.
- Capital Leases steadied at $5000.0 in Q1 2026 per MTNB's latest filing, from $5000.0 in the prior quarter.
- Over five years, Capital Leases peaked at $22000.0 in Q4 2022 and troughed at $5000.0 in Q4 2025.
- A 5-year average of $14285.7 and a median of $14500.0 in 2024 frame the typical range for Capital Leases.
- The sharpest annual moves came in 2022 and 2025: Capital Leases jumped 633.33% in 2022, then sank 58.33% in 2025.
- A 5-year view of Capital Leases shows it stood at $22000.0 in 2022, then slipped by 18.18% to $18000.0 in 2023, then tumbled by 33.33% to $12000.0 in 2024, then slumped by 58.33% to $5000.0 in 2025, then changed by 0.0% to $5000.0 in 2026.
- Business Quant data shows MTNB's Capital Leases at $5000.0 in Q1 2026, $5000.0 in Q4 2025, and $11000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Matinas BioPharma Holdings | 4.60 Mn | 2.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 15,000.00 |
| Mar 31, 2024 | 16,000.00 |
| Dec 31, 2023 | 18,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Mar 31, 2023 | 21,000.00 |
| Dec 31, 2022 | 22,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 5,745.00 |
| Jun 30, 2021 | 11,508.00 |
| Mar 31, 2021 | 17,134.00 |
| Dec 31, 2020 | 23,660.00 |
| Sep 30, 2020 | 30,054.00 |